Compare NREF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NREF | EMBC |
|---|---|---|
| Founded | 2019 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.2M | 200.5M |
| IPO Year | N/A | 2021 |
| Metric | NREF | EMBC |
|---|---|---|
| Price | $14.87 | $3.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $14.00 | ★ $18.50 |
| AVG Volume (30 Days) | 68.8K | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 13.95% | 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.67 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | $10.47 | N/A |
| P/E Ratio | $4.78 | ★ $4.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.36 | $2.77 |
| 52 Week High | $16.13 | $15.55 |
| Indicator | NREF | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 27.72 |
| Support Level | $14.47 | $3.02 |
| Resistance Level | $15.15 | $3.48 |
| Average True Range (ATR) | 0.47 | 0.17 |
| MACD | -0.15 | 0.15 |
| Stochastic Oscillator | 26.32 | 17.31 |
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.